Skip to content
Home/GPs/Sobera Capital
Sobera Capital

Sobera Capital

Berlin, Germany·Founded 2010··sobera-capital.com

Sobera Capital is a Berlin-based independent private equity firm founded in 2010 that provides liquidity and management solutions to private equity investors through secondary-direct acquisitions of company portfolios, single assets and limited-partnership stakes across ICT, industrial technologies and healthcare, and it takes majority and minority direct interests in the underlying operating companies and actively manages them to exit.

AUM
Funds
4
vintages 2013–2020
Portfolio
9
Exits
14

Key facts

HQBerlin, Germany
Founded2010

Recent exits

Memo Therapeutics
Memo Therapeutics
Biotech2026 · 8yr hold
EnOcean
EnOcean
Deep Tech2024 · 8yr hold
EffRx Pharmaceuticals
EffRx Pharmaceuticals
Pharma2023 · 5yr hold
ERS electronic
Industrials2023 · 7yr hold

Coverage notes

4 funds tracked, 23 portfolio companies (9 active · 14 realized). Verified weekly from public filings and deal announcements.

Sector breakdown

23 companies
Biotech
6 · 26%
Software
4 · 17%
Deep Tech
3 · 13%
MedTech
3 · 13%
Pharma
2 · 9%
Consumer
1 · 4%
Data & Analytics
1 · 4%
HealthTech
1 · 4%

Funds & portfolio

Every fund Sobera Capital has raised, with its portfolio companies. Hand-checked from public filings.

4 funds
Sobera Capital Fund VSecondariesActive
2020 · 6yr1 active · 1 realized

Unrealized

1 held
Cortus
CortusActive
Deep TechFrance· Entry 2020

Realized

1 exit
salveco
salvecoExited 2021
ConsumerFrance· Entry 2020
Trade Saleto
Sobera Capital Fund IVSecondariesHarvesting
2017 · 9yr2 active · 5 realized

Unrealized

2 held
MedTechGermany· Entry 2018
PharmaUnited States· Entry 2018

Realized

5 exits
AxellisExited 2022
MedTechUnited Kingdom· Entry 2018
PharmaSwitzerland· Entry 2018
Trade Saleto
Memo Therapeutics
Memo TherapeuticsExited 2026
BiotechSwitzerland· Entry 2018
Trade Saleto
MyoScienceExited 2019
MedTechUnited States· Entry 2018
Trade Saleto
PanoratioExited 2021
Data & AnalyticsGermany· Entry 2015
S-Refit AGSecondariesHarvesting
2016 · 10yr6 active · 6 realized

Unrealized

6 held
CuradisActive
BiotechGermany· Entry 2016
Isarna
IsarnaActive
BiotechGermany· Entry 2016
knowis
knowisActive
SoftwareGermany· Entry 2016
multimmune
multimmuneActive
BiotechGermany· Entry 2016
safectory
safectoryActive
SoftwareGermany· Entry 2016
solvatio
solvatioActive
SoftwareGermany· Entry 2016

Realized

6 exits
AmicraExited 2018
Deep TechGermany· Entry 2016
Trade Saleto
BioMAXExited 2022
HealthTechGermany· Entry 2016
EnOcean
EnOceanExited 2024
Deep TechGermany· Entry 2016
ERS electronicExited 2023
IndustrialsGermany· Entry 2016
Secondaryto
lophiusExited 2021
BiotechGermany· Entry 2016
Trade Saleto
tm3Exited 2022
SoftwareGermany· Entry 2016
Trade Saleto
Sobera Capital Fund IISecondariesRealized
2013 · 13yr0 active · 2 realized

Realized

2 exits
OneAccess NetworksExited 2017
TelecomFrance· Entry 2013
Trade Saleto
PierisExited 2014
BiotechUnited States· Entry 2013
IPO
Track Sobera Capital

Saved GPs appear in your watchlist, one click from your workspace.

About Sobera Capital

Sobera Capital is a private equity firm based in Berlin, Germany, founded in 2010. It is registered with BaFin as an Alternative Investment Fund Manager and is a member of the German private equity association. The firm manages closed-end fund vehicles, with Sobera Capital Fund I and Fund II publicly referenced. Assets under management are not publicly disclosed. Sobera operates in the secondary-direct segment, acquiring existing portfolios of company stakes, single assets and limited-partnership interests, and also offering fund and portfolio management as a service to current owners. As a BaFin-regulated manager running its own funds and holding direct company stakes, it operates as a general partner.

Investment thesis

Sobera Capital provides liquidity and management solutions to private equity investors via secondary-direct transactions, acquiring portfolios of direct company interests plus selective single-asset and limited-partnership-stake purchases. It targets European growth and small-cap funds and assets, with direct secondary reach extending across North America, Western Europe and the MENA region. Sector focus is information and communication technology, industrial technologies and healthcare and life sciences. Ticket size runs up to €50 million. The value-creation lever is hands-on management and active stewardship of acquired portfolios, including taking over management responsibility for orphaned or end-of-life fund assets.

Recent activity

Sobera Capital's portfolio is organised across information and communication technology, industrial technologies and healthcare companies, built through secondary-direct portfolio acquisitions of European small-cap and growth assets. Specific recent named investments and exits are not disclosed in primary sources, consistent with the firm's discreet secondary-direct model and private deal flow. The platform continues to deploy across European secondary-direct opportunities. Detailed buyer names and multiple data available on Pro at €29/month.

Get the full picture on Sobera Capital.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Save this GP to your watchlist
Saved searches that re-run your sourcing filters in one click
Geography breakdown across 5 geographies
Exit buyers and MOIC on every realized deal (Pro)
Export, compare GPs side by side (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Last updated March 2026 · Sourced from public filings · Report an issue